---
title: BioPharma Services Inc. vs Krescent Medical Research
slug_a: biopharmaservices
slug_b: krescentmr
site: cro
review_signal_gate: closed
canonical_path: /compare/biopharmaservices/krescentmr
---

# BioPharma Services Inc. vs Krescent Medical Research

Side-by-side profile data from each company listing on this directory.

## BioPharma Services Inc.

- Profile: [/companies/biopharmaservices](/companies/biopharmaservices)

BioPharma Services Inc. — Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs.

Services: 10. Modalities: 1. Indications: 4. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Phase I Clinical Trials
- Phase II Clinical Trials
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule

### Indications

- Immunology
- Neurology
- Cardiovascular
- Infectious Disease

### Phases

- Phase I
- Phase II

### Sourcing models

- Full-Service Outsourcing (FSO)

## Krescent Medical Research

- Profile: [/companies/krescentmr](/companies/krescentmr)

Krescent Medical Research — Full-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific.

Services: 9. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)